| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.73 | 0.007 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |